Matthias Schwab
Innsbruck Medical University(AT)Witten/Herdecke University(DE)German Cancer Research Center(DE)Universität Innsbruck(AT)American Association of Colleges of Pharmacy(US)Heidelberg University(DE)Robert Bosch Hospital(DE)Universitätsklinikum Tübingen(DE)Hôpital Beau-Séjour(CH)National Center for Tumor Diseases(DE)Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)Research Institute for Work, Technology and Culture(DE)University Children's Hospital Tübingen(DE)German Centre for Cardiovascular Research(DE)Jena University Hospital(DE)Sana Klinikum Offenbach(DE)Hertie Institute for Clinical Brain Research(DE)PharmacoGenetics (China)(CN)Deutsches Herzzentrum München(DE)University Hospital Ulm(DE)Guided Therapeutics (United States)(US)Technical University of Munich(DE)Medical University of Vienna(AT)American University in Cairo(EG)University of Tübingen(DE)KU Leuven(BE)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Acute Lymphoblastic Leukemia research, Estrogen and related hormone effects, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → A roadmap for graphene(2012)9,057 cited
- → Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation(2013)3,981 cited
- → Metformin improves healthspan and lifespan in mice(2013)1,408 cited
- → Prenatal developmental origins of behavior and mental health: The influence of maternal stress in pregnancy(2017)1,125 cited
- → Reduced Paneth cell α-defensins in ileal Crohn's disease(2005)963 cited
- → NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression(2004)795 cited